Substituted oxazolidinones
February 3, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAminomethyl oxooxazolidinyl benzenes useful as antibacterial agents Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents 5'Indolinyl-5ଲ-amidomethyloxazolidin-2-ones Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents Oxazolidone derivative Benzoxazolyl- and benzothiazolyloxazolidinones Adhesion receptor antagonists III Inventors
ApplicationNo. 794034 filed on 02/03/1997US Classes:514/236.8, Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.)514/252.06, Polycyclo ring system having the additional five-membered hetero ring as one of the cyclos514/256, 1,3-diazines (e.g., pyrimidines, etc.)514/331, Nitrogen attached indirectly to the piperidine ring by nonionic bonding514/340, Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.)514/365, 1,3-thiazoles (including hydrogenated)514/367, Bicyclo ring system having the thiazole ring as one of the cyclos514/374, 1,3-oxazoles (including hydrogenated)544/137, The five-membered hetero ring has at least oxygen and nitrogen as ring hetero atoms544/238, 1,2-diazines which contain an additional hetero ring544/324, Additional hetero ring which is unsaturated544/369, 1,3-oxazole ring or 1,3-thiazole ring (including hydrogenated)544/405, Additional hetero ring which is unsaturated546/208, Ring nitrogen in the additional hetero ring546/256, Additional hetero ring containing546/271.4, 1,3-oxazoles (including hydrogenated)548/171, Nitrogen bonded directly to the -C(=X)- group548/178, Chalcogen or nitrogen attached directly to the other cyclo of the bicyclo ring system by nonionic bonding548/196, Chalcogen or additional nitrogen bonded directly to the -C(=X)- group548/215, 1,3-oxazoles (including hydrogenated)548/217, Polycyclo ring system having the oxazole ring as one of the cyclos548/221, Chalcogen bonded directly at the 2-position of the oxazole ring548/231, 3-position substituent contains ethylenic or acetylenic unsaturation or nitrogen548/235Plural double bonds between the ring members of the oxazole ringExaminersPrimary: Dees, Jose G.Assistant: Lutz, Laura R. C. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/42C07D 413/14 Foreign Application Priority Data1996-02-06 DEAbstractThe present invention relates to new substituted oxazolidinones of the general formula (1) ##STR1## in which the substituents have the meaning indicated in the description, processes for their preparation and their use as medicaments, in particular as antibacterial medicaments.Other References
Field of SearchAdditional hetero ring containing1,3-oxazoles (including hydrogenated) Ring nitrogen in the additional hetero ring Additional hetero ring which is unsaturated Additional hetero ring which is unsaturated 1,2-diazines which contain an additional hetero ring 1,3-oxazole ring or 1,3-thiazole ring (including hydrogenated) The five-membered hetero ring has at least oxygen and nitrogen as ring hetero atoms 1,3-oxazoles (including hydrogenated) Plural double bonds between the ring members of the oxazole ring Chalcogen or additional nitrogen bonded directly to the -C(=X)- group Nitrogen bonded directly to the -C(=X)- group Chalcogen or nitrogen attached directly to the other cyclo of the bicyclo ring system by nonionic bonding Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.) 1,3-diazines (e.g., pyrimidines, etc.) Nitrogen attached indirectly to the piperidine ring by nonionic bonding Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.) 1,3-thiazoles (including hydrogenated) Bicyclo ring system having the thiazole ring as one of the cyclos 1,3-oxazoles (including hydrogenated) |
| ||||||||||||||
